Genomic evidence for reinfection with SARS-CoV-2: a case study-Reference-Cited by-同舟云学术

Genomic evidence for reinfection with SARS-CoV-2: a case study

Published:2021-01 Issue:1 Volume:21 Page:52-58
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Tillett Richard L,Sevinsky Joel R,Hartley Paul D,Kerwin Heather,Crawford Natalie,Gorzalski Andrew,Laverdure Chris,Verma Subhash C,Rossetto Cyprian C,Jackson David,Farrell Megan J,Van Hooser Stephanie,Pandori Mark

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. Human neutralizing antibodies elicited by SARS-CoV-2 infection;Ju;Nature,2020

2. The time course of the immune response to experimental coronavirus infection of man;Callow;Epidemiol Infect,1990

3. Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients;Chang;Clin Diagn Lab Immunol,2005

4. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease;Huang;medRxiv,2020

5. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome;Liu;J Infect Dis,2006

Cited by 618 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China;Frontiers in Public Health;2024-05-01

2. COVID-19 reinfections in Mexico City: implications for public health;Frontiers in Public Health;2024-02-14

3. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population;Nature Communications;2024-02-02

4. From intramuscular to nasal: unleashing the potential of nasal spray vaccines against coronavirus disease 2019;Clinical & Translational Immunology;2024-01

5. COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2;Molecular Medical Microbiology;2024